BMP4 Protein

BMP4 Protein — Bone Morphogenetic Protein 4

<div class="infobox infobox-protein">
<table>
<tr><th colspan="2" style="background:#e8f4f8; text-align:center; font-size:1.1em;">BMP4 Protein</th></tr>
<tr><td><strong>Protein Name</strong></td><td>Bone Morphogenetic Protein 4</td></tr>
<tr><td><strong>Gene</strong></td><td>[BMP4](/entities/bmp4-gene)</td></tr>
<tr><td><strong>UniProt ID</strong></td><td>[P12644](https://www.uniprot.org/uniprot/P12644)</td></tr>
<tr><td><strong>PDB IDs</strong></td><td>3BMP, 1REW</td></tr>
<tr><td><strong>Molecular Weight</strong></td><td>~47 kDa (prepro); ~13 kDa (mature monomer); ~26 kDa (active dimer)</td></tr>
<tr><td><strong>Subcellular Localization</strong></td><td>Secreted; extracellular matrix-associated</td></tr>
<tr><td><strong>Protein Family</strong></td><td>TGF-β superfamily, BMP subfamily</td></tr>
<tr><td><strong>Signaling Type</strong></td><td>Paracrine/autocrine growth factor</td></tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/cancer" style="color:#ef9a9a">Cancer</a>, <a href="/wiki/carcinoma" style="color:#ef9a9a">Carcinoma</a>, <a href="/wiki/ms" style="color:#ef9a9a">Ms</a>, <a href="/wiki/tumor" style="color:#ef9a9a">Tumor</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">22 edges</a></td>
</tr>
</table>
</div>

Overview

BMP4 Protein — Bone Morphogenetic Protein 4

<div class="infobox infobox-protein">
<table>
<tr><th colspan="2" style="background:#e8f4f8; text-align:center; font-size:1.1em;">BMP4 Protein</th></tr>
<tr><td><strong>Protein Name</strong></td><td>Bone Morphogenetic Protein 4</td></tr>
<tr><td><strong>Gene</strong></td><td>[BMP4](/entities/bmp4-gene)</td></tr>
<tr><td><strong>UniProt ID</strong></td><td>[P12644](https://www.uniprot.org/uniprot/P12644)</td></tr>
<tr><td><strong>PDB IDs</strong></td><td>3BMP, 1REW</td></tr>
<tr><td><strong>Molecular Weight</strong></td><td>~47 kDa (prepro); ~13 kDa (mature monomer); ~26 kDa (active dimer)</td></tr>
<tr><td><strong>Subcellular Localization</strong></td><td>Secreted; extracellular matrix-associated</td></tr>
<tr><td><strong>Protein Family</strong></td><td>TGF-β superfamily, BMP subfamily</td></tr>
<tr><td><strong>Signaling Type</strong></td><td>Paracrine/autocrine growth factor</td></tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/cancer" style="color:#ef9a9a">Cancer</a>, <a href="/wiki/carcinoma" style="color:#ef9a9a">Carcinoma</a>, <a href="/wiki/ms" style="color:#ef9a9a">Ms</a>, <a href="/wiki/tumor" style="color:#ef9a9a">Tumor</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">22 edges</a></td>
</tr>
</table>
</div>

Overview

Bone Morphogenetic Protein 4 (BMP4) is a secreted signaling molecule of the TGF-β superfamily that plays critical roles in neural development, astrocyte differentiation, and adult brain homeostasis[@varga2008]. First identified for its ability to induce ectopic bone formation, BMP4 is now recognized as one of the most important morphogens in nervous system patterning — it establishes dorsal-ventral identity in the neural tube, regulates neural crest cell specification, controls the balance between neurogenesis and gliogenesis, and modulates neural stem cell quiescence in the adult brain[@chetrun2010].

In the context of neurodegeneration, BMP4 signaling is dysregulated in multiple diseases. BMP4 is upregulated in reactive [astrocytes](/entities/astrocytes) surrounding amyloid plaques in [Alzheimer's disease](/diseases/alzheimers-disease), where it drives astrocytic hypertrophy and inhibits neurogenesis in the hippocampal subgranular zone[@hegarty2013]. In [Parkinson's disease](/diseases/parkinsons-disease), BMP4 promotes astrocyte differentiation at the expense of dopaminergic neuron generation from neural stem cells. Conversely, BMP4 signaling can be neuroprotective by suppressing inflammatory [microglial](/entities/microglia-in-neurodegeneration) activation and promoting oligodendrocyte maturation in demyelinating conditions[@sullivan2015].

Structure

Biosynthesis and Processing

BMP4 is synthesized as a 408-amino-acid prepropeptide that undergoes sequential processing:

Cystine Knot Fold

The mature BMP4 monomer adopts the characteristic TGF-β superfamily cystine knot fold:

• Three intramolecular disulfide bonds form a ring structure (C14–C79, C43–C111, C47–C113) that threads through each other, creating the cystine knot
• One intermolecular disulfide bond (C82–C82') links two monomers in an antiparallel, "hand-in-hand" orientation
• The dimer presents two receptor binding interfaces — each composed of the wrist epitope (type I receptor binding) and the knuckle epitope (type II receptor binding)[@matsumoto2017]

Extracellular Regulation

BMP4 bioavailability is tightly regulated by secreted antagonists:

• Noggin: High-affinity BMP4 antagonist that blocks both type I and type II receptor binding sites; critical for neural induction (Noggin expression in Spemann organizer)
• Chordin: Binds BMP4 and sequesters it in inactive complexes; cleaved by BMP1/Tolloid metalloproteases to release active BMP4
• Follistatin: Binds BMP4 with moderate affinity; primarily associated with activin inhibition
• Gremlin: BMP antagonist expressed in the CNS; modulates BMP4 signaling in adult neurogenic niches[@brewer2019]

Signaling Pathway

Canonical SMAD Signaling

BMP4 signals through a heteromeric receptor complex:

Non-Canonical Signaling

BMP4 also activates SMAD-independent pathways:

• TAK1-p38 MAPK: Promotes astrocyte differentiation and inflammatory responses
• PI3K-AKT: Promotes cell survival; relevant to neuroprotection
• JNK: Context-dependent; can promote either survival or death
• ERK1/2: Crosstalk with FGF signaling during neural patterning[@kaur2021]

Normal Function in the Nervous System

Neural Tube Patterning

BMP4 is secreted from the roof plate of the developing neural tube, establishing a dorsal-to-ventral gradient that specifies dorsal cell fates (sensory interneurons, neural crest). This gradient opposes the ventral [Sonic Hedgehog](/entities/shh-gene) (SHH) gradient from the floor plate:

• High BMP4: dorsal interneurons (dI1-dI3)
• Low BMP4: intermediate progenitors
• No BMP4 + high SHH: motor [neurons](/entities/neurons), ventral interneurons[@park2022]

Neural Crest Specification

BMP4 at intermediate concentrations (at the neural plate border) induces neural crest cell specification. These cells migrate to form the peripheral nervous system, melanocytes, craniofacial structures, and enteric nervous system[@liu2023].

Gliogenesis Switch

A pivotal function of BMP4 in the developing and adult brain is promoting the astrocyte fate at the expense of neurogenesis:

• Developmental gliogenic switch: BMP4/SMAD signaling activates [GFAP](/entities/gfap) and S100β promoters while repressing proneural genes (Mash1/Ascl1, Ngn1/2)
• Adult neural stem cells: BMP4 in the hippocampal subgranular zone and subventricular zone maintains stem cell quiescence and promotes astrocytic differentiation. Noggin expression in these niches counterbalances BMP4 to permit neurogenesis[^11]

Oligodendrocyte Maturation

In the postnatal brain, BMP4 has complex effects on [oligodendrocytes](/entities/oligodendrocytes):

• Inhibits OPC differentiation: BMP4 blocks oligodendrocyte precursor cell differentiation into mature, myelinating oligodendrocytes by maintaining them in an immature state
• Promotes astrocyte trans-differentiation: At high concentrations, BMP4 can redirect committed OPCs toward an astrocyte fate
• Context-dependent myelination effects: Moderate BMP4 promotes myelin maintenance, while excessive BMP4 inhibits remyelination after injury[^12]

Role in Neurodegenerative Disease

Alzheimer's Disease

BMP4 is significantly upregulated in AD brain, particularly in reactive astrocytes surrounding amyloid plaques:

• Reactive astrogliosis: BMP4 drives GFAP upregulation, process hypertrophy, and proliferation of reactive astrocytes in the peri-plaque environment. The BMP4→SMAD1/5/8→ID1 pathway is a major driver of the A1 reactive astrocyte phenotype
• Neurogenesis impairment: Elevated BMP4 in the hippocampal dentate gyrus suppresses adult neurogenesis, contributing to memory deficits. Noggin infusion or BMP receptor inhibition rescues neurogenesis in [APP](/entities/app-protein)/PS1 mice
• Amyloid-β interaction: [Aβ42](/proteins/amyloid-beta) oligomers directly stimulate BMP4 expression in astrocytes via [NF-κB](/entities/nf-kb) signaling, creating a feed-forward loop: Aβ → astrocytic BMP4 → impaired neurogenesis + astrogliosis → reduced Aβ clearance
• [APOE](/proteins/apoe)-dependent modulation: [APOE4](/diseases/apoe4) astrocytes produce more BMP4 than APOE3 astrocytes in response to Aβ, potentially explaining the exaggerated gliosis and neurogenesis impairment in APOE4 carriers[^13]

Parkinson's Disease

• Dopaminergic neuron specification: BMP4 normally suppresses the dopaminergic fate during midbrain development (SHH + FGF8 + WNT1 promote dopaminergic differentiation; BMP4 opposes this). Dysregulated BMP4 in the aging substantia nigra may impair compensatory neurogenesis
• Cell replacement therapy: Understanding BMP4 inhibition is critical for iPSC-derived dopaminergic neuron protocols; dual SMAD inhibition (LDN193189/SB431542) is the standard method for deriving midbrain floor plate progenitors from pluripotent stem cells[^14]

Multiple Sclerosis and Demyelination

BMP4 is a major barrier to remyelination:

• BMP4 is upregulated in MS lesions, preventing OPC differentiation into myelinating oligodendrocytes
• Noggin, anti-BMP4 antibodies, or small-molecule BMP receptor inhibitors (LDN193189, DMH1) promote remyelination in cuprizone and EAE models
• BMP4 antagonism is being explored as a remyelination therapy[^15]

Stroke and Ischemia

BMP4 expression increases dramatically after ischemic stroke:

• Elevated BMP4 in the peri-infarct zone inhibits neuroblast migration from the SVZ to the injury site
• BMP4 promotes glial scar formation (beneficial for containment, detrimental for regeneration)
• Noggin infusion into the lateral ventricle increases neuroblast migration to the ischemic penumbra[^16]

Therapeutic Targeting

BMP4 Pathway Inhibitors

| Compound | Target | Stage | CNS Application |
|----------|--------|-------|-----------------|
| LDN193189 | BMPR1A/ALK2 kinase | Research/preclinical | Promotes remyelination, neurogenesis |
| DMH1 | BMPR1A/ALK2 kinase | Research | Selective BMP inhibitor; promotes OPC differentiation |
| K02288 | BMPR1A/ALK2/ALK6 kinase | Research | Promotes neurogenesis in adult SVZ |
| Dorsomorphin | BMPR1A/AMPK (non-selective) | Research | Original BMP pathway inhibitor; off-target AMPK effects |
| Recombinant Noggin | BMP4 ligand (extracellular) | Preclinical | Rescues neurogenesis in AD models |

Therapeutic Strategies

Key Interactions

• [BMPR1A](/proteins/bmpr1a-protein) (ALK3): Primary type I receptor for BMP4 in the CNS
• [BMPR2](/proteins/bmpr2-protein): Type II receptor; constitutively active kinase
• SMAD1/5/8: Downstream transcription factor effectors
• [SMAD4](/proteins/smad4-protein): Co-SMAD required for nuclear translocation
• Noggin: High-affinity extracellular antagonist
• Chordin: Extracellular BMP4 sequestrant
• ID1/ID2/ID3: Target transcription factors; inhibit bHLH proneural genes
• [SHH](/genes/shh): Opposing morphogen gradient in neural tube patterning
• BMP1/Tolloid: Metalloprotease that cleaves Chordin to release BMP4

See Also

• [BMP2 Protein](/proteins/bmp2-protein)
• [TGF-β Signaling in Neurodegeneration](/mechanisms/tgf-beta-signaling)
• [Neural Stem Cells](/cell-types/neural-stem-cells)
• [Astrogliosis](/mechanisms/reactive-astrogliosis)
• [Oligodendrocyte Differentiation](/mechanisms/oligodendrocyte-differentiation)

External Links

• [UniProt: P12644](https://www.uniprot.org/uniprot/P12644)
• [NCBI Gene: BMP4](https://www.ncbi.nlm.nih.gov/gene/652)
• [PDB: 3BMP](https://www.rcsb.org/structure/3BMP)
• [OMIM: 112262](https://www.omim.org/entry/112262)

References